Parkinson's disease - Search News

Ozzy Osbourne crippled by disease

Ozzy Osbourne's final show: Black Sabbath to reunite amid frontman's Parkinson's disease

Ozzy Osbourne will come out of touring retirement and reunite with the full Black Sabbath lineup for the first time in 20 years.

People on MSN · 20h

Ozzy Osbourne Can No Longer Walk Due to Parkinson’s Ahead of Final Show with Black Sabbath

Sharon Osbourne gave an update on how Parkinson’s disease has impacted husband Ozzy Osbourne’s legs as the musician prepares to reunite with Black Sabbath in July for his final concert.

AL.com on MSN · 1h

Ozzy Osbourne crippled by disease, to perform one last time with iconic band

Sharon Osbourne, his wife, told The Sun her husband’s voice is still up to the task of performing.

Parkinson's disease, Daniel Barenboim

Hosted on MSN · 14m

Red flags of Parkinson's disease as mum is diagnosed at just 28 years old

Nicole LaBolle initially dismissed her shaking as something fairly common before facing a Parkinson's diagnosis at 28

The New York Times · 21h

Daniel Barenboim Announces He Has Parkinson’s Disease

Daniel Barenboim, the eminent conductor and pianist who stepped back from engagements in recent years citing health concerns, said Thursday that he has Parkinson’s disease.

The Associated Press on MSN · 19h

Conductor Daniel Barenboim says he's been diagnosed with Parkinson's disease

Conductor Daniel Barenboim says he has been diagnosed with Parkinson's disease. The 82-year-old issued a statement Thursday on Instagram. He has appeared more frail since 2022, canceling scheduled performances that included a new production of Wagner's Ring Cycle in Berlin.

2d

Drug Similar to Ozempic Failed to Treat Parkinson’s Disease in a Trial

The study may suggest that other researchers should be less optimistic about the prospects for treating a range of other ...

MedPage Today17h

Why Did a GLP-1 Receptor Agonist Fail This Parkinson's Trial?

The GLP-1 receptor agonist exenatide failed to meet its primary outcome in a phase III trial of Parkinson's disease patients.

Despite Early Promise GLP-1 Disappoints in Parkinson’s Disease

Exenatide had no disease-modifying effects in a phase 3 trial Parkinson’s disease, despite earlier evidence from a phase 2 ...

Hosted on MSN17h

Supernus wins FDA approval for Parkinson’s pump on fourth try

Supernus Pharmaceuticals has won US approval for its wearable pump Onapgo (apomorphine hydrochloride) to treat symptoms of ...

MedPage Today2d

FDA OKs New Wearable Treatment for Parkinson's Disease

The FDA approved an apomorphine hydrochloride infusion device (Onapgo) to treat motor fluctuations in adults with advanced ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results